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Cancer is a major global health problem that affects people all over the world 
regardless of their age, gender or social class and has been established as major leading 
cause of death. According[1] lung cancer, thorax cancer and prostate cancer are among 
the common oncological diseases in Russia giving the country a high mortality rate of 
26%, among Russian men for instance the cancer mortality is at 212 per 100,000 
population when compared to other European countries. Thorax cancer occurs in the 
chest cavity while lung cancer begins in the lung tissues and prostate cancer is 
concentrated in the prostate gland.  The treatment of cancer largely depends on three 
modalities that is surgery, radiotherapy and chemotherapy. These modalities can be 
used as a combination or separately. Currently radiotherapy emerges as one of major 
and widely used modality, however its success depends on accurately delivering a 
radiation beam to the area of interest. In radiotherapy the goal is to deliver a high 
precise amount of radiation dose to the tumor while sparing surrounding vital organs. 
The need to continuously achieve this goal has led to development of more advanced 
and complex treatment techniques which make use of multi-leaf collimator. Among 
complex technique is Intensity modulated radiation therapy (IMRT) and volumetric 
modulated arc therapy, they are widely used as the conform more precisely dose to the 
target and spare much more better organs at risk compared to conventional. 
IMRT/VMAT uses small segment to generate very complex dose distribution that 
shapes the tumor, hence require high multi-leaf accuracy positioning to reduce dose 
delivery errors with minimum segment width the minimum separating distance 
between opposing leaves can be obtained. The plans must be optimized and verified to 
insure patient specific quality assurance, verification can done by applying the 
treatment plan to a dosimetric phantom and compare measured dose to calculated dose, 
this process allows to detect any existing mismatches between planned and delivered 
doses [2]. By verify the quality complex plan as IMRT/VMAT we can be confident 





Statement of the problem 
One important aspect in radiation therapy is the accuracy of radiation dose 
being administered to the patient, in this case radiation therapy is faced some 
challenges that must be overcome for a successful treatment. One of the challenges is 
assuring quality dose delivery of the plan, providing dose consistence between planned 
dose and measured doses. IMRT/VMAT uses small segments to create complex dose 
distribution that will shape the tumor and require high multi-leaf collimator position 
accuracy to reduce dose delivery errors, MLC inaccuracies can have a direct impact on 
the dose distribution. 
One parameter that is used to determine the minimum leaf separation between 
opposing leaves is segment width. By changing parameters such as minimum segment 
width (MSWs) we simply change the complexity of the plan and the linear accelerator 
(LINAC) may not be able to deliver dose to the patient as it was calculated in the 
treatment planning system (TPS) therefore there must be correlation between the 
measured dose and TPS calculated dose. IMRT and VMAT QA, requires good 
reproducibility of the measured dose. There are some Published studies that 
investigated the reproducibility of individual measurements for instance Mancuso 
GM[3] investigated the reproducibility of the ion chamber, film and 2D diode array 
measurements in patient specific IMRT QA the work was based on the structure set 
geometry and not actual clinical plans. Fraser too [4] investigated the reproducibility 
of various ion chambers for IMRT QA and McKenzie[5] investigated the 
reproducibility of IMRT QA across a wide array device. However, no known study 
that has explored IMRT and VMAT optimization of dose distribution and determine 
universal minimum segment width (MSW) for IMRT and VMAT plans based on 3D 
dosimetric phantom for thorax cancer, prostate cancer and lung cancer 
treatmentObjectives 
To investigate the influence of segment width of intensity modulated 






To compare results of 2D and 3D dose verification at different segment width. 
To determine an optimal and acceptable minimum segment width criterion for 
thorax cancer, lung cancer and prostate cancer plans. 
Research Questions 
Are there correlations between results of 2D and 3D dose verification process? 
What is the optimal value of minimum segment width determined to be used 




















Chapter 1 Literature review  
1.1 Radiotherapy in cancer treatment 
As described by [6] Cancer remains a major cause of death at global level. 
According to [7] the international research agency for research on cancer announced 
in 2008 that most accurate assessment of global cancer burden show that 7.6 million 
deaths and over 12.7 million new case occurred in developing countries. In addition 
from [8] world health organization (WHO) on top ten commonly diagnosed  incidence 
of cancer in the year 2020 showed prostate cancer as the second leading cancer disease 
and cause of death while lung cancer recorded at third position, with a highest mortality 
rate recorded for lung among all the ten common cancer incidences worldwide. This 
just shows the important and need for accurate radiotherapy treatments. In 2012 there 
were over 8.2 million deaths, prostate cancer was estimated at 307,000 deaths 
representing 6.6% of the total male cancer mortality, as evident from these records of 
these researchers [8], [9]and 1.1 million cases worldwide were recoded with almost 
70% of them occurring in more developed region, the commonly diagnosed cancer was 
lung cancer at 1.82 million and it recorded the most cause of death at 1.6 million deaths, 
liver cancer at 745,000 deaths and stomach at 723,000 million deaths. With such past 
and recent records and estimate, specialist from various disciplines all around the world 
work to effectively and efficiently provide patients with optimal radiotherapy treatment 
and care.  
From [11] At least half of all cancer patients will require radiotherapy at some 
stage during their treatment. [10]radiotherapy has continued to grow and evolve for the 
last years such as the invention of high energy radiotherapy delivered by a cobalt 60 
machine (CO60) or a linear accelerator (LINAC), scientific advances and improved care 
hence improving therapeutical outcomes and reduced side effects. Among advances 
include the technologies that maximizes and increase conformity of prescription dose 
to the tumor at the same time minimizing exposure to normal surrounding organs and 
tissues including intensity modulated radiotherapy and [11]Volumetric modulated arc 
therapy among others.  
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Radiotherapy is now widely used to treat all cancer case including lung, 
prostate, thorax, breast, liver commonly diagnosed cancer worldwide. [12] it can be 
used preoperatively to shrink cancer cell and improve respectability or used in 





Figure 1.2.1-1_mortality rate estimation 2020 worldwide 
 
 
Figure 1.2.1-2_ cancer incidence rates worldwide 
 
1.2 Intensity modulated radiotherapy  
Thorax cancer, lung cancer and prostate cancer are among the common 
diagnosed cases. Radiotherapy has proved to be an effective mode of treatment for in 
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the past years especially for these cases, however planning treatment can be a challenge 
because there is need to maximize dose to the target and spare the healthy tissue. 
Fortunately advances in external beam radiation therapy techniques have provided 
techniques that help achieve maximum dose like intensity modulated radiation therapy 
(IMRT). IMRT is a successful accepted technology in radiation therapy since the origin 
of inverse planning and computed tomography (CT) in 1982, since then it has gained 
popularity and is now used as a default option on most recent linear accelerator and 
treatment planning system (TPS).  According to rim et al [13] in a survey to determine 
the rate use of IMRT in Korea, they found that there was a steady increase usage in 
2016 and they estimated that the rate is likely to be over 50% by 2017. Also the 
radiation oncology respondent of a 2002 and 2004 US survey on the use of IMRT 
indicated an increase from 32% to73% users [14]  It can be predictable that every center 
performs IMRT for patient that benefits from it. [15]defines IMRT as a radiation 
treatment technique with several beams having beams that are intensity modulated and 
intentionally delivering a non-uniform intensity on to the tumor, in this case the desired 
dose distribution in the target can be achieved. intensity modulated radiotherapy 
enables the escalation of dose to the target for instance to the prostate while reducing 
the toxicities to the rectum and the bladder leading to an improved local control and 
decrease complications as compared to conventional, three-dimensional conformal 
therapy(3D-CRT)[14]. 
 
1.2.1 Intensity modulated radiotherapy planning treatment 
The acknowledgment that dose distribution could effectively be achieved by 
IMRT provides the physicians a sense of relieve that a problem in radiation treatment 
plan can finally be handled. This technique has proved to be more different than older 
treatment techniques as 3D conformal radiation therapy(3D-CRT) whose fields 
conform to the beams eye view (BEV) outline of the target volume[16]. IMRT planning 
as a dose delivered by treatment plans that are optimized. IMRT uses multi-leaf 
collimators (MLC)shaping by using mode like step and shoot, sliding window and 
volumetric modulated arc therapy (VMAT). It is important that when planning IMRT 
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target volume and critical structures are shown so as to assist in providing a correct 
prescribed dose, to this regard an optimization plan must be generated that will achieve 
the target volume dose requirement and the dose constraints, thereby restricting dose 
exposure to vital structures[17]  
Optimization of the plan is vital in IMRT, it is a process of exchange between 
target coverage and dose strains to critical organs finding an optimal plan to use, it is 
done using various methods and algorithms, there is setting of physical dose objectives 
and constraints then analyzing dose volume histograms (DVH) and biological planning 
objectives until the prescription objective is achieved. Every patient’s anatomy predicts 
a special or different kind of beam orientation, by utilizing computer and human 
optimization better plans can be obtained for better patient treatment outcome. 
 
1.2.2 IMRT treatment delivery 
Intensity modulation radiotherapy treatment is effectively administered using 
multi-leaf collimator (MLC), MLC consists of many separate leaves designed to shape 
radiation fields and deliver designed dose, these leaves can move separately in and out 
of the radiation beam blocking unwanted areas. Every separate leaf can be managed 
independent of the others thereby generating a field opening pattern designed to 
conform to the target volume [17]. In around 1984 first commercial MLC was devised 
and used by scanditronics, later on other linac vendors employed it in their equipment’s 
due to the beneficial results that were seen and now linac companies have even 
improved radiality of MLC and have designed even small leaf width. With smaller leaf 
widths we can enable the treatment planning system to apply even finer beamlet size 
that irradiate at different times during the optimizing stage and achieve a good plan 
quality [18]. IMRT treatments are delivered by using static beam angles or circulating 
beams, all these forms have existed since the invention of IMRT technology. [19]the 
field segment can be delivered dynamically for instance MLC changing through the 
field segment dynamically while the beam is on and delivery can be through one 




1.3 Volumetric modulated arc therapy (VMAT) 
Over the past years there has been technological advance in radiation therapy 
techniques and deliveries, these are attributed to acquiring a greater conformal dose 
distribution and improving treatment results. VMAT was made known in 2007, it 
defines a technique that allows modulation of multi-leaf collimator ,gantry rotation 
speed and dose rate simultaneously during treatment [20].  VMAT is different from 
fixed beam IMRT in that radiation is delivered while the gantry rotates around the 
patient, continuously reshaping and changing the intensity of the radiation beam as it 
moves around the patient increasing accuracy delivery. Clinical application of VMAT 
is increasing significantly as it can be used to treat very complex tumor sites including 
thoracic, lung, prostate, brain, head and neck cancers among others [21]. Many studies 
have been reported on VMAT technique for example a report by [22] concluded that 
the techniques is safe modality for all cancer types. [23] published an earliest VMAT 
planning study in 2008 indicating advantages of VMAT such as dose distribution and 
short time treatment. VMAT techniques allows treating of the target volume with one 
or more arcs depending on how the complex the plan is. VMAT systems are available 
in various brands like rapid Arc, smart Arc, Elekta VMAT [21]. 
 
1.4 Dosimetric tools used for IMRT/VMAT QA 
In order to ensure an effective and efficient implementation of IMRT there are 
several tools that have been put in place so that day to day clinical practice can yield 
better results. Researchers have reviewed and compared different dosimetry tools that 
can be used especially for IMRT/VMAT. The widely used tools include detectors, 
scanners, phantoms and dosimetric analysis tools. [24] describes these tools in details 
putting out how they are to be used and cases where they cannot be applied.  
Detectors have evolved from 1-D through 2-D and 3-D even 4D detector 
systems are now available, for 1-D we have examples such as ion chambers TLDs and 
MOSFET, they have their own weakness and strength for instance ion chamber are 
easy to calibrate, they are capable of measuring absolute dose and they come in 
different shapes and sizes, however they can only make one measurement point for 
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each irradiation providing less information to evaluate dose through the entire target 
volume. Examples of 2-D detector arrays are films like radiographic and radio chromic, 
2-D detectors such as Mapcheck and ion chamber linear array. Taking for instance 
radiographic films that are very sensitive to storage condition, in spite this they are 
readily available, not as expensive as other 2-D detectors, and can give excellent 
resolution.  Now many dosimetry tools exist, for example a study that analyzed and 
compared the dose distribution of different IMRT and VMAT plans with intentions to 
provide pretreatment QA using different tools, they considered Delta4 phantom, ion 
chamber and used gamma evaluation. [25] In another study to compare the quality 
assurance results of IMRT researchers used four different dosimetric tools that is they 
irradiated radio chromic film, a diode array, an ion chamber and an electron portal 
imaging device for patients specific quality assurance [26].  
Due to increase in the use of complex treatment plan such as IMRT/VMAT 
there is need to study efficient and most reliable techniques for performing QA for such 
plans. [27] this study used three systems of ion chamber with film, 2-D diode array and 
2D ion chamber array, the study concludes that these systems can be used for VMAT 
QA provided the user understands and is attentive to the strength and limitations of the 
QA devices. In another study that used 2D planar diode arrays and 3-D cylindrical 
diode arrays in IMRT and VMAT found that both detectors have excellent performance 
for IMRT and VMAT verification[28] . All these reports encourages that all users 
should be aware of each tool they intend to use. Knowledge of dosimetric tools and 
technique will allow user to be able to perform QA with appropriate tools for even 
complex treatment techniques giving them a wide range of choices. 
Table 2.1.2.1-1_ specifications of different common dosimetry systems designed for 
IMRT QA purposes 

















2D array 2D array 2D 
array/cylinder 
cylinder cylinder 





0.64 15.9 19.4 0.64 0.78 
Detector 
volume(cm3) 
0.000019 0.08 0.06 0.000019 0.000039 
Detector 
distance(mm) 
1.01 7.62 7.1 10 5/10 
Number of 
detectors 
1527 1020 1405 1386 1069 
Detector 
pattern 
Plane Plane Plane  cylinder 2ortho-
planes 
Max field size 32 x 26 24.4 x24.4 27 x 27 27 20 
Weight  7.1 - 6/29 16 27 
 
1.5 The need for pretreatment verification 
The main objective of pretreatment QA is to verify that the treatment plan will 
deliver the planned dose distribution within the specified tolerance [29]. Therefore, for 
complex treatment plan such as IMRT which utilizes linear accelerator with dynamic 
multi-leaf collimators there is need to perform specific patient quality assurance for the 
so reason that the predicted dose by the treatment planning system is actually the actual 
dose being delivered to the patient during treatment[30].  
Treatment plans that indicate differences between the measured and calculated 
dose distribution and exceed the specified tolerance requires that the plan be 
reconsider. We can only determine these differences by performing pretreatment 
verification QA using phantoms and dose measuring device. Furthermore [28]agrees 
that QA is necessary for ensuring that the intensity map pattern matches with the TPS 
and the MU specified by the TPS will deliver an intended dose. [31], [32]both reports 
recommend verification measurements for patient specific QA for IMRT and VMAT, 
users must create time for dosimetric verification and investigate problems if any.  
The verification process for specific patient verification quality assurance (QA) 
can be summarized as firstly verifying the patient planning parameters and MLC, it is 
then required that dose measurement equipment is scanned and transfer data to 
planning computer creating verification plan, then move treatment information to 
record and verification system and finally results are then compared. There are a wide 
range of commercial dosimetry systems devices designed for dose measurement for 
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IMRT QA, this research considered ArcCHECK cylindrical detector array designed 
for rotational dosimetry and a software system known as 3DVH from Sun Nuclear 
corporation. 
 
1.6 ArcCHECK for IMRT/VMAT treatment verification QA  
ArcCHECK dosimetry system is one of the newly three-dimension detector 
design especially for rotational radiation deliveries QA verification process, it is 
suitable system for IMRT and VMAT treatment plans and has been recommended by 
AAPM task group 218 for 3D measurement requirements. The system was developed 
by Sun Nuclear Corporation in order to aid rotational therapy QA [33], [34]. It is 
cylindrical in shape and is used for measurement of radiation dose. ArcCHECK can 
take measurement at any angle this enables identifying even small gantry angle miss 
outs that can be missed when using 2D detectors, a good spatial resolution even for 
very small leaf width of 3mm is observed [33]. ArcCHECK provides so many features 
that enable complex treatment QA easier according to ArcCHECK user guide,2009, 
reports describe the phantom as designed to look like a patient simulating geometry so 
as to match reality. The specification of the phantom is shown in figure 3, it consists 
of 1386 diodes detectors arranged in a cylindrical style, detectors are spaced at 1.0 cm. 





Figure 1.2.2-1_shows specifications of ArcCHECK-Diode dosimetric system 
Since the invention of the phantom, its applicability and reliability of the data 
continue to be reported and reviewed by several researchers. [35] evaluate the 
dosimetric accuracy of new treatment modality using ArcCHECK, it was reported that 
the plans gave a good agreement and the system can provide good measurement. [35] 
furthermore ArcCHECK can give substantial information through simple and easy 
procedure. [28]reported that the system is excellent for IMRT and VMAT verification, 
form these reports we can deduce already that ArcCHECK system is ideal for complex 
QA verification and that it can be used in everyday clinical practice  
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Table 2.1.2.1-1_Advantages and disadvantages of ArcCHECK-Diode 
 
1.7 3-DVH software for IMRT/VMAT treatment verification QA 
Due to the increased use of complex treatment plans in clinical practice the 
desire for dosimetry verification and QA is increasing too. Three-dimensional dose 
volume histogram is a software package designed by sun nuclear to assist further 
analysis of measurement dose especially to specific region of interest. The system takes 
into account all possible measurement errors encountered during delivery and any if 
errors exist between measured dose and calculated TPS dose, the system back projects 
theses errors into the original treatment plan. This process allows obtaining of 3D 
perturbed distribution of dose which reflects errors detected and gives actual 
measurements. 3DVH allows analysis of target volume and risk organ separately so we 
can visualize and understand where exactly the error is or rather discrepancies in 
measurement. [36]the 3-D gamma metric that is obtained and the DVH of ROIs can be 
used to compare and transform the QA process to a more patient centered than phantom 
centered. The accuracy of the system has widely been studied in many studies, [36], 
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[37]evaluated the effectiveness of 3DVH software with ArcCHECK 3-D diode array 
detector and the writer recommended the use of the software for IMRT QA.  
The advantages of 3DVH software system may include: 
- Provision of fast results with automated tools 
- No need of commissioning  
- Allowing the user to further analyze the result in terms of 3D gamma index 
and DVH regions of interest 
- Allows errors to be traced back to the actual treatment plan  
The known drawbacks on the software may include: 
- It is only compatible to specific dosimetry systems  
- It requires already existing measurements from device to be able to compare 
with treatment plan. 
1.8 linear accelerator Elekta synergy 
Intensity modulated radiation therapy (IMRT) and volumetric modulated arc 
therapy (VMAT) are linear based modalities meaning that they use linear accelerator 
equipped with multi leaf collimators (MLC). One of the earliest linear accelerators 
designed to meet the needful criterial of IMRT and VMAT is Elekta Synergy linear 
accelerator invented by Elekta corporation. The linac is equipped with MLC which, 
allows the beam to be shaped according to the shape of the tumor. Elekta synergy 
accelerator uses agility multi-leaf collimator with 160 leaves Interdigitating tungsten 
alloy leaves with a width projected to the isocenter of 5mm and a maximum filed size 
at the isocenter of 40 x 40 cm2 , each leaf bank is joined to a dynamic leaf guide and 
combined speed of these two components can reach 6.5cm per second closely twice as 
fast as conventional MLCs [38]. The position of all leaves is monitored and controlled 
by optical camera located in the collimator of the linac, the leaf movement is done by 
high torque electric motors stopping the leaf from assuming incorrect positioning. The 
ability of the collimator to provide exceptional 45cm distance from the patient is 
important for IMRT/VMAT. IMRT /VMAT requires all these features for excellent 
and successful operation  
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The invention of Elekta Synergy linac achieves one important feature that is 
required for complex techniques that is the ability to visualize internal structure. It was 
the first linac to sort out 3D image guidance into treatment set up process, with imaging 
tools such as 3D and 4D volumetric cone beam for soft tissue delineation these features 
are incorporated along with Elekta Synergy linac. Elekta Synergy provides 
personalized, safe, effective and high-quality radiation enhanced dose conformity 
according to tumor size, shape and pathology, this technology has improved tumor 
control probability, reduction of secondary tumors and minimized side effects[39]. 
Elekta Synergy is consisting of a couch for supporting and positioning the 
patient, electronic portal imaging device (EPID), gantry, kV imaging system and a 
stand as external components. The internal components comprise of the accelerating 
wave, bending magnets, circulator, a cooling system, electron gun, energy selector 
klystron/ magnetron, wave guide and the treatment head, the treatment head contains 
components required for beam production and shaping, target, beam shaping 
collimators and optical distance indicator[40]. 
          Table 2.1.2.1-1_ specifications of Elekta Synergy 
 
Elekta Synergy has many advantages: that fully integration of multi-leaf 
collimator, digital treatment center to personalize imaging and treatment workflows, 
offering real time patient position verification. The large diameter around the isocenter 




1.9 Monaco treatment planning system (TPS)  
The wide use of Radiotherapy in clinical practice requires physicians to be 
more accurate than ever as this modality has greatly improved in many areas such as 
delivery techniques leading to very fast and more complex treatment with higher 
dosage delivery to targeted site and shorter fractionation schemes. Therefore, treatment 
planning systems ought to be fast accurate, automated sensitive and incorporated to 
treatment machines. In order to alleviate challenges faced with treatment planning 
system of complex treatment modalities and provide efficient and effective features, 
Monaco treatment planning system was designed.  
It is one of the commonly used planning systems all around, its increased 
application is due to several beneficial features that improve plan quality. [41] The 
treatment planning system puts together monte Carlo dose calculation with powerful 
optimizing tools to give high quality radiation treatment plans. Monte Carlo (MC) 
algorithms are the gold standard for dose computing dose in radiotherapy[41], MC dose 
engines simulate particles, tracking individual interactions and secondary generated 
particles and then tally dose deposition in a medium[41]. Monaco is designed to 
generate plans that spare as much healthy tissues as possible while maximizing the 
dose to the target volume utilizing multicriterial optimization (MCO). It is well suited 
and provides solution for 3-D, IMRT, VMAT, SBRT and SRS.  
Monaco technology allows quick calculations allowing physicians and patients 
benefits from the accuracy of monte Carlo algorithm while reducing overall planning 
time. collection of biological and physical dose-based planning tools and templates 
makes the planning process easy [42]. [43]Monaco templates improves efficiency by 
allowing users to import and export treatment plan using DICOM services. It provides 
user to design treatment plan and visualize the final planned dose results. It is possible 
also to come up with multiple prescriptions continuously this can decrease treatment 
Elekta Synergy linear accelerator together with Monaco treatment planning system 
combine unrivalled dose delivery and intelligent dose planning.  
Advantages are many these include offering comprehensive contouring, plan 
review tools to support modern treatment modalities. Ability to define organ response 
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rates with constrained optimization. There is accuracy that does not interfere with MC 
algorithm leading to precise accuracy for different tissue densities. It is said to be a 
trend toward improved target dose conformity, resulting in fewer segments leading to 

























Chapter 2 Materials and Methods  
2.1 Elekta Synergy linear accelerator(linac) 
For delivery quality assurance of the plans, an Elekta Synergy (Elekta, ltd) 
linear accelerator was used to deliver photon beam of 6MV and 10MV.The linac is 
installed at Tomsk Regional Oncology Clinic in Tomsk, Russia where the study was 
conducted.  It is equipped with 160 agility mulileaf collimator with a field size of 40 x 
40 cm2 external component include couch for supporting and positioning the patient, 
electronic portal imaging device (EPID), gantry, kV imaging system and a stand. Two 
strategies of IMRT with multi-leaf collimator were used in the study one is dynamic 
technique (DMLC), were the MLC leaves move continuously while the radiation beam 
is on but the gantry is fixed in one position, the second is volumetric modulated arc 
therapy (VMAT) the MLC leaves move continuously and gantry rotates around the 
patient while the radiation beam is on. Both of these techniques work to produce a dose 
that conforms to the shape of the target volume in the chosen field trajectory with 
minimal exposure to normal organs. 





The combination of benefits from Monaco TPS with IMRT/VMAT into Elekta 
Synergy significantly reduces treatment times, meaning more patients can receive 
modulated treatment per day. Elekta synergy is used exclusively for modulated 
treatment allowing the clinic to treat many patients with modulated radiation therapy 
every day. 
 
2.1.1 Patients’ cases 
Statistics indicate high levels of thoracic cancer including lung cancer and 
prostate cancer among men and women regardless of the age and gender. Henceforth, 
three localizations of patients with thorax, lung and prostate cancer were selected from 
the clinical database. Patients were treated with external IMRT and VMAT. four plans 
were generated for each case and planned following test case plans from AAPM TG-
244 report. All plans were obtained by incorporating minimum segment width of 
0.5cm, 1.0cm, 1.5cm and 2.0cm with 0.5cm increment. 
All patients were scanned using computed tomography imaging scanner in 
rotational mode and the reconstructed CT images were transferred to Monaco 5.11 
TPS, contouring of CT images was done in Monaco software to avoid variation in 
Figure 1.2.2-1_Elekta synergy linac 
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system regarding to contour interpolation. From the CT image the target volume and 
vital structures were defined. Dose prescription was at 68Gy in 2Gy/fraction. For 
thorax cancer case the dose prescribed was at 60Gy in 2Gy/fraction and for lung 
prescribed dose was at 63Gy in 1.8Gy/fraction.  
 
2.1.2 Monaco treatment planning system (TPS) 
This study was conducted using Monaco treatment planning system a widely 
accepted treatment planning system (TPS) with optimization scheme. Monaco TPS is 
a complete IMRT treatment planning system which supports several delivery modes 
including step and shoot IMRT, VMAT and many other. This study used Monaco 
version 5.11 TPS for contouring, planning dose, optimization of plan and evaluating 
the plan for delivery quality assurance quality,  
Table 2.1.2.1-1_ Total dose and Fractionations and dose per fraction 










Technique  Collimator 
and couch 
angles (00 ) 
Lung  63 1.8 35 6.0 
MV 
IMRT 0 
Thorax  60 2.0 30 6.0MV VMAT 0 
Prostate  68 2.0 34 10MV VMAT 0 
 
2.1.2.1 Minimum segment width 
Optimizing IMRT and VMAT plans involves two step processes, the first step 
process allows creating and optimizing ideal fluence to suit prescription, this is done 
using optimizing algorithms. The   second step process allows the ideal fluence 
obtained in the first step to be translated into a deliverable form set of MLC segments 
delivery. It is at this stage that setting of constraints for generating MLC segments is 
obtained such as settings for minimum segment width was placed at this step. After 
obtaining deliverable fluence dose was optimized and calculated for each plan. 
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Minimum segment width is a parameter of Monaco that is used to correct the 
minimum width of the segments, like minimum separation of a leaf pair. It allows 
lessening effects of bad MLC calibration and leaf positioning accuracy.  
The range of values allowed in the optimizer is starting from0.5cm to 2.0cm 
maximum. For this study four plans were devised with different penalties on minimum 
segment width (MSW) of 0.5cm, 1.0cm, 1.5cm and 2.0cm for each case of the study.  
 
Figure 2.1.2-1_ showing MLC pattern. 
                             
2.2 AAPM TG-244 REPORT 
In year 2014, AAPM task group 244(TG-244) published an important report 
that aims at providing commissioning and quality assurance of treatment planning dose 
calculations for photon and electron beams. The practice guidelines recommended 
ways of validating the dose for intensity modulated radiotherapy (IMRT), volumetric 
modulated arc therapy (VMAT)and helical delivery plans by simply comparing 
individual beams or composite measurements with the treatment planning system 
calculations. In addition to this, the group set out ways establishing a routine quality 
assurance program that does not only improve but helps to validate dose consistency 
through recalculation of reference plans for both megavoltage photon and electron 
beams, the task group established six sample datasets these datasets of respective tumor 
cases are widely accepted and applied for routine quality assurance. 
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Therefore, this study followed the recommendations so as to be able to provide 
high quality plans. Three case type were selected for the study, that is TG-244-Thorax 
patient, TG-244-Lung patient and TG-244-Prostate patient.  
 
2.2.1 IMRT/VMAT dosimetric verification 
It is necessary to verify the accuracy of radiation delivered by carrying out tests 
such as delivery quality assurance (QA) prior to patient treatment especially for high 
precision and complex treatments such as IMRT/VMAT.  
 
2.2.2 ArcCHECK 2-D Dosimetric verification 
Dosimetric verification of IMRT/VMAT QA plan was performed using 
ArcCHECK diode detector, it is a 3D detector that measured the 2D %GPR for 
differences between measured dose by the dosimeter and TPS calculated dose. 
Comparison of unfolded 2D profile from the dosimeter surface. Below is shown the 
obtained sample results of ArcCHECK-SNC.  [36] defines ArcCHECK as a 
cylindrical, and water equivalent phantom specifically designed for rotational beam 
delivery verification (QA) with 1,386 3D spiral positioned detectors , a diode interval 
of 1cm just within the cylinder, an active size of about 0.8cm x0.8cm and a diameter 
of 21cm, its length is 21cm and detector depth is of 2,89cm [45].  
A software program SNC patient was utilized to measure the 2D pass rate for 
differences between delivered dose and dose calculated dose in TPS.  A gamma 
criterion of 3%/2mm with a threshold of 20% was applied. The plan passes if greater 




Figure 2.2.2-1_ ArcCHECK plan verification 
 
2.2.3 3-DVH Software -3D Dosimetric verification 
3DVH-software was used further analysis of measured dose thereby comparing 
the refence dose to comparison dose. Sets of data were transferred to 3-DVH Software, 
these include, TPS-optimized patient plan, dose distribution, contoured structures and 
CT images, corresponding TPS- calculated dose measured results and  ArcCHECK 
measured data were then changed to 3-D dosimetric data using PDP algorithm and 
compared against the original treatment plan that was transferred from TPS using 3-D 
gamma analysis (3mm DTA,2%DD global), And the dose difference found for each 
beam were projected back into TPS 3D dose calculation, to get actual delivered 3D 
dose distribution.  
The results from the software were displayed as DVH of the reference (TPS) 
and compared dose distributions, with this software I was able to analyze the gamma 
passing rate of each corresponding region of interest (ROI).  
The % deviation (DE) between DVH values from 3DVH and TPS were 











      …………………..1 
Here 3 DVHD −     is the dose value calculated from 3-DVH software  
 TPSD   is the dose value extracted from TPS, calculated from for each plan the 
region of interest (ROI). 
 
Figure 2.2.3-1_ A schematic design of the study. Patient specific QA methods using ArcCHECK-
SNC and 3DVH software package 
 
2.2.4 Gamma analysis evaluation 
The gamma analysis method gives gamma index values to each individual point 
where a gamma index value of ≤1 means a passed and a greater value will represent a 
failed. So, the results of passing points in the gamma distribution expressed in 
percentage is collective known as gamma pass rate(%GPR). For this study a value of 
≥95%(%GPR) was set as a pass percentage with a dose difference (∆D) and distance 




Chapter 3 Results and Discussion   
Verification of delivery quality is vital process of quality assurance. In this 
study, IMRT-VMAT dose calculated in Monaco TPS were verified by using a water 
equivalent cylindrical phantom ArcCHECK together with SNC-patient and 3DVH 
software package. Planned dose was compared to measured dose distributions. For all 
optimized treatment plan 90% to 99% of prescribed dose encompassed 95% of tumor 
volume. The plan efficiency and delivery accuracy were evaluated and the results from 
the study evaluated the total number of segments, total number of monitor units and 
dosimetric measurement verification results using a global normalized gamma index 
criterion with ArcCHECK -SNC patient (2-D gamma pass rate), 3DVH for 3-D gamma 
pass rate and DVH-based metric of target volume and region of interest (ROI). 
3.1 Planning quality evaluation 
Lung localization  
3.1.1 Total monitor units and number of segment width at different 
segment width 
Table 3-3.1 _  monitor units and number of segments per segments width 
Lung location 
MS Total number of segments  Total monitor unit 
0.5 194 667.22 
1.0 189 542.18 
1.5 192 472.34 
2.0 176 454.70 
 
From the table it is seen that as the minimum segment width increases total 
number of monitor units decreases, it is at the highest segment width that we find the 
lowest number of segment and decreases monitor units indicating shorter treatment 
time. For case of lung cancer where intra and inter fraction can be possible the segment 




3.1.2 Dose distribution and target coverage per segment width 
The results evaluated how dose conforms to the planning target as segment 
width was changing. 
Very conformal dose distributed in the target volume reducing dose to 
surrounding structures was seen to have improved more at segment width of 0.5cm and 
1.5cm when compared to 2.0cm. looking at the dose distributed and target dose 
coverage in all the plans the prescribed dose covered 95% target volume. There were 
was not very much differences in minimum doses to vital regions however, plans at 
0.5cm and 1.5cm showed decreased exposure of organs at risk. All in all, the plans 
were of good quality and ready to be delivered.  
3.1.3 Statistical dose volume histogram per segment width  
To make a through plan evaluation dose distribution and dose histogram (DVH) 
of Monaco TPS were generated, this helps to precise evaluate the extent of dose to 
surrounding structures and to determine that a sufficient treatment dose is attributed to 
the tumor volume without exceeding the dose threshold for normal tissues, it is 
Figure 3-3.1.2-2_ dose distribution of lung cancer Figure 3.1.2-1_ dose distribution of lung cancer 
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important that the plan objectives are meet. In this analysis was done using statistical 
DVH so critically see where differences may occur. 











0.5 PTV-63 50.524 73.880 0.92 0.21 
1.0 49.796 75.364 0.97 0.32 
1.5 51.300 77.710 0.81 0.65 




60.687 67.817 8.79 - 
1.0 61.349 69.008 1.53 - 
1.5 59.978 69.546 1.40 0.004 
2.0 59.211 68.416 5.07 - 
0.5 CTV-63 57.036 73.880 3.09 0.20 
1.0 56.969 75.364 1.24 0.30 
1.5 57.424 77.697 1.36 0.55 
2.0 46.815 73.671 4.50 0.33 
 
Table 2.1.2.1-2_ organs at risk DVH 









0.697 - 1.03 
1.0 0.703 - 1.03 
1.5 0.710 - 1.03 
2.0 0.656 - 1.02 
0.5  
 
Esophagus (min)   
0.640 - 48.78 
1.0 0.671 - 48.95 
1.5 0.644 - 49.10 




(max)   
30.057 - - 
1.0 31.496 - - 
1.5 30.887 - - 
2.0 31.192 - - 
 
From these results is shown doses to planning target, some existing differences 
are indicated in the mean and maximum doses with presence of some cold regions with 
the highest record at 2.0cm. Some percent areas of hot spots are also observed with 
varying segment width the highest percent is seen at 1.5cm, however 0.5cm and 1.5cm 
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indicate that the minimum dose receive to the planning target was of good quality 
compared to the minimum dose delivered at segment with 2.0cm very small amount is 
seen which may not help treat the target volume as indicated in the prescription.  
Looking at vital surrounding structures there was no observed much differences 
in the minimum dose and maximum dose. 
Thorax localization  
3.1.4 Total monitor units and number of segment width at different 
segment width. 
Table 2.1.2.1-1_ monitor units and number of segments per segments  width 
Thorax location 
Parameter  Total number of segments Total monitor unit 
0.5 70 385.81 
1.0 72 331.83 
1.5 72 331.83 
2.0 69 424.83 
 
Thorax case shows a lower number of monitor units at segment width of 1.0cm 
and 1.5cm however the lowest number of segments is observed at 2.0cm. the decrease 
in monitor units and number of segments can indicate a shorter treatment time for 
patient and can be beneficial in avoiding motion effect. 
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3.1.5 Dose distribution and target coverage per segment width  
The figure shows dose in grays delivered to planning structures with respect to 
the color. All the plans indicated a 95% dose coverage with little insignificant 
variations per segment width.  Organs at risk received negligible small doses. Hence 
the plans were successful. 

















57.535 69.747 - 3.87 
1.0 56.316 68.255 0.04 1.04 
1.5 56.316 68.255 0.04 1.04 
2.0 55.410 68.670 0.11 6.00 
0.5  
 
CTV_P   
61.917 67.340  7.97 
1.0 61.656 67.312  1.89 
1.5 61.656 67.312  1.89 
2.0 62.553 67.155  4.72 
 
It is clear from the table that there were no significant variations in all the plans 
in the mean dose and maximum dose, however small percent cold spots are seen with 
Figure 3-2 dose distribution for thorax cancer Figure 3.1.4 dose distribution fo  thorax canc r igure 3.1.5-1_ dose distribution for thorax cancer 
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increase in segment width. For planning quality efficiency all plans were good and 
successful.  
Table 2.1.2.1-2_organs at risk 
 
Looking at organs at risk like the heart the plans spared high doses to these 
regions indicating quality plans readiness for delivery.0.5cm ,1.0cm and 1.5cm seemed 
better than 2.0cm which showed high percent of cold regions. 
Prostate localization  
3.1.6 Total monitor units and number of segment width at different 
segment width 
Table 2.1.2.1-1_ number of segments and total monitor units per segment width 
Prostate location 
Parameter  Total number of segments Total monitor unit 
0.5 136 748.56 
1.0 141 679.95 
1.5 132 643.15 
2.0 126 569.15 
 
With increasing the minimum segment width, the total monitor unit increases 
and decreases with decreasing the segment width, hence at 2.0cm the lowest monitor 
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unit is calculated and it is at this segment that the lowest number of segments is 
observed. 
3.1.7 Dose distribution and target coverage per segment width 
Evaluating the dose distributed to planning volume and surrounding vital 
organs, there is significantly no notable differences as the segment width changes. All 
the plans indicated a 95% dose coverage with little insignificant variations per segment 
width.  Organs at risk received negligible small doses. Hence the plans were successful. 














74.551 60.726 0.40  
1.0 74.669 60.770 0.69  
1.5 74.680 59.373 0.86  
2.0 75.063 58.461 1.04  
 
Figure 3-3 dose distribution of prostate cancer Figure 3.1.7-1_ dose distribution of prostate ca cer 
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The dose maximum and minimum dose to PTV in all the plans were similar as 
shown in the table relatively very little insignificant difference are seen. Although 
segment width 2.0cm shows the highest percent volume of cold spot with the lowest 
seen at 0.5cm, the maximum dose is best achieved at 1.0cm and 1.5cm. 
Table 2.1.2.1-2_ organs at risk 
MSW 
(cm) 






0.5 Bladder  7.609 82.15 - 
1.0 9.845 82.03 - 
1.5 11.555 81.98 - 




2.126 87.52  
1.0 2.183 88.04  
1.5 2.091 87.29  
2.0 2.277 87.55  
  
The minimum doses to OARs changed with change in segment width. Looking 
at the bladder it increased with increasing segment width otherwise the other risk 
structures showed no differences as shown in the table.  
3.2 Dosimetric verification (QA results) 
3.2.1 ArcCHECK-SNC(2D) and ArcCHECK-3DVH(3D) gamma pass 
rates at different segment width. 
In this section the results present comparison of dosimeter measured dose and 
planned TPS at different segment width for thorax cancer, prostate cancer and lung 
cancer.  
Gamma passing rate was calculated at 3% dose difference and 2mm distance 
to agreement and a threshold of 20% with a pass rate of ≥95% was used to obtain 
optimum segment width for IMRT and VMAT plans. The results were established for 






Table 2.1.2.1-1_ showing gamma passing rates at different segment width and 
treatment location 
Lung location 
Minimum segment (cm) 2D %GPR 3D %GPR 
0.5 95.4 97.7 
1.0 93.6 95.5 
1.5 94.4 97.1 
2.0 91.4 95.8 
Prostate location 
Minimum segment (cm) 2D %GPR 3D %GPR 
0.5 84.5 79.8 
1.0 88.1 83.1 
1.5 82.7 83.4 
2.0 86.8 89.3 
Thorax location 
Minimum segment (cm) 2D %GPR 3D %GPR 
0.5 93.8 97 
1.0 97.9 99 
1.5 97.9 99 
2.0 94.7 97.4 
 
3.2.1.1 ArcCHECK-SNC(2D) verification   
The results obtained here show comparison of ArcCHECK-SNC measured 
dose and TPS calculated dose, the level of agreement was obtained from the gamma 
pass rate as indicated in the table above hence the following were the results: 
For lung cancer the gamma pass rate was 95.4%, 94.6%, 94.4% and 91.4%, at 
0.5cm,1.0cm,1.5 and 2.0cm respectively, hence, increasing segment width the pass rate 
slightly decreases and the plan quality did not improve much compared to plans at 
lower segment width. The estimated deviation is said to be within a <3%. The plan of 
0.5cm showed a pass rate greater than 95%. 
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Thorax case indicated 93.8%, 97.9%, 97.9% and 94.1% at 0.5cm,1.0cm,1.5 and 
2.0cm respectively, the highest pass rate is seen at 1.0cm and 1.5cm segment width and 
prostate cancer the gamma pass rate recorded 84.5%, 88.1%, 82.7%, and 86.8% at 
0.5cm,1.0cm,1.5 and 2.0cm respectively with a deviation higher than 3%, the results 
for prostate cancer were poor as they did not pass the set criteria of ≥95%. 
In general, the highest GPR% for lungs are observed at minimum segment 
width of 0.5cm, Thorax case indicated highest GPR% value 97.9% and 97.15 at 1.0cm 
and 1.5cm respectively while prostate cancer shows a high pass rate but below the 
acceptable level of 88.1% respectively at minimum segment width of 1.0cm and can 
considered for QA treatment planning. In case of thorax, deviation falls at ≤3%. 
Meanwhile, for lung cancer at MSW at 1.0 and 1.5 a slightly higher deviation outside 
3% was seen the value does not show clinical significance. 
 
3.2.1.2 ArcCHECK-3DVH(3D)  
From table 3.2.1.2-1.  results obtained from 3DVH verification using 3D 
gamma pass rate at 3%/2mm criterion for plans are shown. At 0.5cm segment width 
the GPR% was 95%, 93.8%, and 84.5% for lung cancer, thorax cancer and prostate 
cancer respectively. Thorax case shows a 100% GPR% at 1.0 and 1.5cm (table 2) 
therefore 1.0cm or 1.5cm minimum segment width is effectively suitable and can be 
considered for IMRT and VMAT thorax case plans as optimum. Meanwhile 0.5cm and 
1.5cm MSW is suitable and can be considered in the planning of lung tumor case as it 
indicates a 97.7% and 97.1%GPR respectively.  
 For prostate cancer GPR% recorded was below 95% indicating poor pass rate 
with regard to the set criteria, no plan passed in this case. In order to find out the reasons 
for poor results 3D dosimetric system ArcCHECK was recalibrated and plans delivered 







Table 3.2.1.2-2 _ showing gamma pass rate of prostate cancer after recalibration of the 
dosimetric ArcCHECK system 
Prostate location 
Parameter  2D 3D 
0.5 84.5 79.8 
1.0 98.7 98.6 
1.5 97.8 98.7 
2.0 86.8 89.3 
 
After recalibration we see improved results that passed the acceptance level, 
segment width 1.0cm and 1.5cm indicate better agreement and consistence. Hence can 
be considered in clinical practice as they have indicated optimum results. It can be 
noted that poor results can come from different aspects such as beam output by linac, 
TPS set up and dosimetric device calibration therefore it is important to investigate the 
problem so as to provide good results. 
3.2.2  Dose distribution per segment width with respect to pass rate 
(GPR%) 
 
Figure 3.2.2-1_ example of dose distribution per segment width for prostate case 
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In order to understand GPR% in relation to dose distribution the results were 
evaluated and the results indicated that for: 
Prostate: some hot spots in risk organs increases at 0.5cm and 2.0cm Hence 
reduction of GPR% at these segment widths. There is high pass rate at 1.0cm and 1.5cm 
due to improved good agreement in the measured dose and calculated dose. 
 Thorax: presences of some cold areas in target volume at minimum segment 
of 0.5cm and 2.0cm resulting in lower GPR% while 1.0cm and 1.5cm show uniform 
distribution with high GPR%. 
 Lung: at 0.5cm high areas of hot spot in target volume and cold spots in organs 
at risk, similar case is observed at 1.5cm resulting in high GPR% while at 2.0cm cold 
spots in target volume and at 1.0 high hot spots in organs at risk resulting in low GPR%. 
 
3.2.3 Dose volume histogram  
The solid lines indicate reference dose while the thin lines/dashed line represent 
comparison doses, color block is shown respective of the targeted structures and organs 
at risk 
Lung case 
Figure 3-5 An example of dose for lung case at segment width 0.5cm and 2.0cm Figure 3.2.3-1_ An example of dose for lung case at segment width 0.5cm and 2.0cm 
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The solid lines indicate dose reference dose while the thin line represent the 
comparison dose, alongside is the color representing the structure under study. In all 
the plans 99% of the volume covered the prescribed dose to the target. 
In terms of dose consistent between the reference dose and the comparison dose 
to target volume at different segment width there is observed more improved good 
agreement at segment width of 0.5cm and 1.5cm compared to segment with of 1.0cm 
and 2.0cm where small variations are seen between reference doses and comparison 
doses. In terms of organs at risk there is not much differences except for the spinal cord 
which shows a slight difference at segment width 0.5cm. otherwise all the plans 
showed very minimal dose at 99% of volume to organs at risk. 
 
Thorax localization 
For thorax localization DVH obtained in all plans showed no big differences 
between planned and comparison doses. However, the plan of 1.0cm and 1.5 showed 
greater agreement compared to other plans. Organs at risk obtained minimum doses 
which were within the constraint. 




Results obtained from DVH at segment width 1.0cm and 1.5cm improved 
consistent agreement between reference and comparison doses is observed while at 0.5 
poor agreement and at 2.0cm we see significant dose variation in the reference dose 
and comparison dose. 




3.2.4 DVH -based metrices evaluation 
DVH -based parameters include reference dose, comparison dose and relative 
deviation dose given in Gy, for organs at risk (OARs) and target volume (PTV min, 
mean, max, CTV mean, min, max, GTV min, mean max) and %GPR were determined 
at different minimum segment widths. 
DVH-based metrices for lung cancer (ROI) 
Lung case 
Table below shows the reference dose distribution, comparison dose 
distribution, the deviation dose and GPR%   For lung cancer at different minimum 
segment width. There was very little differences between the planned doses and 
reconstructed doses resulting in a very insignificant relative deviation of ±1% at every 
segment width. The plans resulted in very good agreement at 0.5cm and 1.5cm segment 
width. There was total target coverage, although slightly increased target coverage at 
lower minimum segment width is observed. The GPR% was >95% despite the change 
in minimum segment width. The segment width at 1.5cm and 0.5 showed higher pass 
rate compared to another segment width hence can be considered. 
Table 3.2.1.2-1_ DVH-based metrices for lung cancer (ROI) 
MSW  Ref(Gy) Comp(Gy)  Diff (Abs/%) Gy  
GPR%   
 
PTV-63 
Min  Mean  Max  Min  Mean  Max  Min  Mean  Max  
0.5 53.6 64.5 72 49.2 64.4 75.9 -5/-8 -0.01/-0.02 3.9/5.5 96.7 
1.0 47.2 64 71.1 46 64.1 75.5 -1.2/-2.6 0.1/0.1 4.5/6.3 95.2 
1.5 53.7 64 74 49.7 63.3 76.8 -4/-1.1 -0.7/-1.1 2.8/3.7 97.1 




61.3 64.5 72 59.3 64.5 75 -1.9/-3.7 -0.09/-0.1 3/ 4.2 97.3 
1.0 53 64.3 71.1 53.9 64.3 75.5 0.8/1.5 -0.01/-0.02 4.5/6.3 96 
1.5 59.3 64.3 74 56.6 63.5 76.8 -2.6/-4.4 -0.8/-1.2 2.8/3.7 96.7 




61.1 64.4 67.7 58.9 64.1 70 -1.9/-3.2 -0.2/-0.3 2.2/3.2 98.8 
1.0 61.1 64.2 68.1 59.5 64 70.1 -1.6/-2.6 -0.2/-0.3 1.9/2.8 97.5 
1.5 61.2 64.2 67.2 58.9 63.3 67.8 -2.3/-3.7 -0.9/-1.4 0.55/0.8 96.4 







To further evaluate dose distribution to surrounding structures outside the target 
volume, DVH -based matrices were obtained analyzing minimum and maximum dose 
and GPR% for each plan.  
With organs at risk for lung cancer, results indicate that the dose maximum, 
dose minimum to these structures (table 5) was even below the institutional 
recommended dose, not only that the dose was consistent too with very small deviation 
within ±3. The GPR% indicate that the plans were in good agreement hence minimum 
segment width of 1.5cm is more suitable and should be considered. 
 
DVH-based metrices for thorax cancer (ROI) 
Thorax case 
Thorax localization, there were some tiny differences observed in the minimum 
dose, mean dose and maximum dose between reference and comparison doses at 
segment width of 0.5cm and 2.0cm this showed very low pass rate. However greater 
agreement is observed at segment width of 1.0cm and 1.5cm indicating high pass rate 
of approximately 100%.  
 




Table 3.2.1.2-3_ DVH-based metrices for Thorax cancer (ROI) 
MSW  Ref Comp  Diff (Abs/%)  
GPR%   
 
PTV-P 
Min  Mean  Max  Min  Mean  Max  Min  Mean  Max  
0.5 58.3 63.6 69.7 54.3 64.2 71.6 -3.8/-6.6 0.6/1 1.9/2.7 89.6 
1.0 56.3 62.8 68.2 56.3 63.2 69.3 0/0.01 0.3/0.6 1.0/0.6 98.3 
1.5 56.3 62.8 68.2 56.1 63 69 -0.2/-0.3 0.1/0.2 0.7/1.1 99 




62 64.7 67.3 61.3 64.9 68.8 -5/-0.8 0.1/0.2 1.4/2.2 99 
1.0 61.6 64.4 67.2 61.2 64.8 67.8 -0.3/0.5 0.3/0.5 0.6/0.8 100 
1.5 61.2 64.4 67.2 61.1 64.5 67.6 -0.5/-0.8 0.1/0.2 0.4/0.6 100 
2.0 62.4 64.8 67.1 62.2 65.3 68.8 -0.1/-0.2 0.5/0.8 1.7/2.5 97.6 
 
From the table it be can deduced that varying minimum segment width did not 
affect the dose distributed to organs at risk, there was no notable difference between 
reference dose and comparison dose, therefore all plans were good and showed 
excellent dose consistent of 100% pass rate. 
Table 3.2.1.2-4 _ DVH-based metrices for thorax cancer (ROI/OARs) 
 
The minimum dose to organs at risk like the heart and the trachea shows no much 
differences there is better agreement especially at 0.5cm,1.5cm and 2.0cm segment 







DVH-based metrices for prostate cancer (ROI) 
Prostate case  
The minimum deviation results between comparison measurement and 
reference showed a decrease with minimum segment width of 1.0cm and 1.5cm ±2, 
hence target coverage decreased at 0.5cm and 2.0cm for the case of prostate cancer. 
The %GPR is seen to have increased at segment width 1.0cm and 1.5cm it is at these 
segments where we see very consistent results agreeing between reference doses and 
comparison doses, these segments are preferred.   
Table 3.2.1.2-5 _DVH-based metrices for prostate cancer (ROI) 
MSW  Ref Comp  Diff (Abs/%)  
GPR%   
 
PTV-68 
Min  Mean  Max  Min  Mean  Max  Min  Mean  Max  
0.5 63.2 69.7 74.5 66.3 73.5 82.1 3.0/4.8 3.7/5.4 7.6/10.2 1.9 
1.0 64.1 69.8 74.7 63.0 68.9 76.2 -1/-1.7 0.1/0.1 1.4/1.8 95.8 
1.5 63.0 69.7 74.3 63.1 70.0 77.1 0.1/0.3 0.6/0.9 2.8/3.7 95.7 




55.2 62.9 73.4 56.2 65.7 78.9 1.0/1.8 2.7/4.4 5.4/7.4 44.8 
1.0 55.6 63.0 74.7 55.2 63.2 75.6 -0.4/-0.7 0.2/0.3 0.8/1.1 96.2 
1.5 55.8 62.4 73.7 54.9 62.4 75.5 -0.9/-1 0.2/0.3 1.8/2.4 97.6 
2.0 55.1 62.1 73.5 55.7 64.3 77.7 0.6/1.1 2.1/3.4 4.1/5.6 65.4 
 
The minimum dose between reference and comparison doses showed no much 
variation to OARs despite the segment width used, except for the bladder whose 
minimum dose differed and increased with increasing segment width. The segment 
1.0cm and 1.5cm showed greater rate of agreement with high pass rates of 98.4% at 
1.0cm and 98.1% at 1.5cm. 
Table 3.2.1.2-6 _ DVH-based metrices for prostate cancer (ROI) 




 Min  Min  Min  
0.5 2.1 2.6 0.4/23 84 
1.0 2.2 2.5 0.3/14 98.4 
1.5 2.1 2.6 0.5/23 98.1 




8.3 9.7 1.3/16 66.7 
1.0 10.9 11.7 0.8/7.4 99 
1.5 13 14 1/8 99.5 







3.2.5 Analysis of 2D and 3D gamma pass rate comparison 
 
Figure 3.2.5-1_ gamma pass rate at various minimum segment width for lung cancer 
 
 
























































Figure 3.2.5-3_ gamma pass rate at various minimum segment width for thorax cancer 
Figure 5_ 1 shows a plotted graph of %GPR for ArcCHECK and for 3DVH, 
the results indicate that using minimum segment width of 0.5cm is optimum, therefore 
in clinical practice one can consider using minimum segment of 0.5cm and 1.5cm for 
lung case. The proceeding figure is for prostate cancer, planning treatment for this case 
showed good results at minimum segment width of 1.0cm and 1.5cm. Considering 
figure 5_3 which shows the pass rate for thorax cancer, the study obtained excellent 
99% pass rate at 1.5cm and 2.0cm minimum segment width, henceforth when planning 






































The need for optimal quality assurance in complex treatment plan such as 
IMRT/VMAT cannot be never be over emphasized. The goal was to optimize dose 
distribution and to determine universal minimum segment width (MSW) for IMRT and 
VMAT plans based on 3D dosimetric phantom for thorax cancer, prostate cancer and 
lung cancer.  It is important to recognize that by varying the minimum segment width 
we change the complexity of the plan and the linac may not be able to deliver the dose 
to the patient as it was calculated in TPS.  
From the results obtained it was determined that changing the minimum 
segment width changes the complexity of the plan and can increase or decrease number 
of segments and total monitor units calculated. There was improved plan quality, 
delivery accuracy and efficiency at optimum segment width with respective to tumor 
sites.  
From quality assurance (QA) results optimum segment width results were 
determined to be 0.5cm and 1.5cm is optimal for lung cancer, 1.0cm and 1.5cm is 
optimal for thorax case. For prostate cancer only after recalibration of ArcCHECK 
dosimetry system were good results obtained, the reason for inconsistency was 
determined and poor results were eliminated, hence 1.0cm and 1.5cm was determine 
to be optimum. This segment width optimally meets the clinical requirement, therefore 
can be considered in clinical practice to improve accuracy dose delivery to patients 
undergoing IMRT and VMAT treatment for thoracic, lung and prostate cancers. The 
results of the study are vital to prostate, thorax and lung IMRT/VMAT only and the 
procedure used to determine the optimum segment width would be used in studies of 
other sites of IMRT/VMAT plans. It is also important to note that results may vary 








Chapter 4 Financial management, resource efficiency and resource saving 
The research investigates the influence of minimum segment width of intensity 
modulated radiotherapy plan based on QA plans, to this regard several resources were 
used and before the implementation of the research it is important to undertake the 
economic aspect of the project.  
Radiotherapy is one effective mode of cancer treatment which has continued to 
gain popularity and advances. Complex treatment plans have been in clinical 
implementation since technological advances in radiotherapy, among these are 
intensity modulated radiotherapy and volumetric modulated arc therapy 
(IMRT/VMAT). These techniques have several advantages and are widely accepted, 
among the main reason of usage is that they allow maximum dose to be delivered to 
the tumor target and spare as much as possible dose exposure to critical organs.   
VMAT and IMRT increase the target coverage, conformity significantly compared 
with conformal radiotherapy (CRT), IMRT/VMAT also increase protection on OARs 
when compared to CRT. VMAT achieves a better dose conformity, less MU and 
shorter delivery time than IMRT. It has been reported on several cancer location that 
IMRT and VMAT can generate non uniform fields to achieve better planning target 
volume coverage while decreasing unnecessary radiation exposure to normal 
organs[46]. [47] study showed that 99.9% of PTV was covered by the prescribed dose 
with IMRT and VMAT compared to 88.9% of CRT. [48]study reported that VMAT 
showed significant dosimetric advantages both on target coverage and OAR sparing 
compared with CRT in the treatment of postoperative cervical cancer. However, no 
significant difference between IMRT and VMAT was observed except for slightly 
better dose conformity, slightly less MU and significant shorter delivery time achieved 
for VMAT. However, the use of such complex plan requires high levels of accuracy in 
exaction. 
 In this study three cancer sites were selected for the study and IMRT/VMAT 
plans generated with different penalties of minimum segment width during plan 
optimization. The research was conducted on clinical base at Tomsk oncology clinic 
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in Tomsk, Russia. Complex equipment and software were used for the research, Elekta 
synergy linear accelerator and ArcCHECK-3DVH dosimetric system for dose delivery 
and verification respectively. Elekta Synergy provides a suite of advanced guidance 
tools, imaging of soft tissue at the time of treatment allows efficient verification of 
tumor and critical structure position, providing increased confidence in dose 
placement. In terms of treatment Delivery Individualized patient care is possible 
through a range of techniques from 3D conformal techniques, through static and 
dynamic IMRT to VMAT. Enhanced dose conformance for individualized patient care 
is observed. [49]Elekta provides excellent beam-shaping capabilities across the range 
of delivery techniques with a range of advanced integrated multi-leaf collimators. 
Through fully integrated digital control with continuous real-time optical verification, 
accurate placement of all leaves allows for faster, safer and more accurate delivery.[50] 
its application is widely seen in several reports. 
Because we cannot irradiate the actually patient during patient quality, we used 
the diode detector which works with 3DVH for dose verification. In order to check the 
accuracy of dose, compare between the planned dose and calculated dose and 
determine the gamma pass rate of each plan. Planning treatment, Monaco treatment 
planning system was used. 
Financial management, resource efficiency and resource saving are an 
important aspect in implementing a project, it helps to measure the prospects and 
success of a research project enabling a plan to for managing and acquiring special 
support for implementation. It involves assessing the commercial potential, 
attractiveness to the target audience, SWOT analysis and so on as will show in this 
research.  
The purpose of this section discusses the issues of competitiveness, resource 
efficiency and resource saving, as well as financial costs regarding the object of study 
of Master's thesis. Competitiveness analysis is carried out for this purpose. SWOT 
analysis helps to identify strengths, weaknesses, opportunities and threats associated 
with the project, and give an idea of working with them in each particular case. For the 
development of the project requires funds that go to the salaries of project participants 
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and the necessary equipment, a complete list is given in the relevant section. The 
calculation of the resource efficiency indicator helps to make a final assessment of the 
technical decision on individual criteria and in general 
4.1 Competitiveness analysis of technical solutions 
In order to find sources of financing for the project, it is necessary, first, to 
determine the commercial value of the work. Analysis of competitive technical 
solutions in terms of resource efficiency and resource saving allows to evaluate the 
comparative effectiveness of scientific development. This analysis is advisable to carry 
out using an evaluation card. 
The first aspect is to analyze possible technical solutions and choose the best 
one based on the considered technical and economic criteria. 
Evaluation map analysis presented in Table below. In order to choose the optimal 
method, IMRT (C1), VMAT (C2), 3DCRT (C3) radiotherapy treatment planning 
techniques were adopted for competitiveness analysis. Where IMRT is intensity 
modulated radiotherapy, VMAT is volumetric modulated arc therapy and 3D-
conformal radiotherapy. The position of this research and competitors is evaluated for 
each indicator on a five-point scale, where 1 is the weakest position and 5 is the 
strongest. The weights of indicators determined in the amount is 1. Analysis of 
competitive technical solutions is determined by the formula: 
i iC W P ,=  , 
С - the competitiveness of research or a competitor; 
Wi– criterion weight; 








Table 3.2.1.2-1 _ Evaluation card for comparison of competitive technical solutions 









coefficients P1 P2 P3 C1 C2 C3 
1 2 3 4 5 6 7 8 
 Technical criteria for evaluating resource efficiency  
1. Delivery time 0,1 4 5 3 0,4 0,5 0,3 
2. Planning efficiency 0,25 4 4 3 1 1 0,75 
3. Dose conformity 0,05 3 5 3 0,15 0,25 0,15 
4. Energy efficiency 0,2 4 5 4 0,8 1 0,8 
5. Reliability of results 0,1 5 5 4 0,5 0,5 0,4 
6. Hardware availability 0,1 4 4 4 0,4 0,4 0,4 
Economic criteria for performance evaluation 
1. Widely accepted method 0,1 5 5 3 0,5 0,5 0,3 
2. Power application 0,05 4 5 4 0,2 0,25 0,2 
3. Price 0.05 4 4 4 0,2 0,2 0,2 
Total 1 37 42 32 4,15 4,6 3.5 
 
The results from the table indicate that every technique has its own pros and 
cons which make them applicable for specific situation in clinical practice, with VMAT 
the best results are seen due to short delivery time and reliability of results but the 
hardware is readily available. However, 3DCRT is simple and easily available but there 
is less dose conformity as compared to the other methods, IMRT show similar score to 
VMAT and is popular however its time-consuming compared to VMAT. These 
techniques can be chosen depending on the specific requirement. However, and (C1) 
and (C2) were used in the study. 
4.2 SWOT analysis 
Complex analysis solution with the greatest competitiveness is carried out with 
the method of the SWOT analysis: Strengths, Weaknesses, Opportunities and Threats. 
The analysis has several stages. The first stage consists of describing the strengths and 
weaknesses of the project, identifying opportunities and threats to the project that have 
emerged or may appear in its external environment. The second stage consists of 
identifying the compatibility of the strengths and weaknesses of the project with the 
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external environmental conditions. This compatibility or incompatibility should help 
to identify what strategic changes are needed. 
Strengths are factors that characterize the competitive side of a research project. 
Strengths indicate that the project has a distinctive advantage or special resources that 
are special in terms of competition. In other words, strengths are the resources or 
opportunities that the project management has and which can be effectively used to 
achieve the goals. 
Weaknesses are a lack, omission or limitation of a research project that impedes 
the achievement of its objectives. This is something that does not work well within the 
framework of the project or where it has insufficient capabilities or resources compared 
to competitors. 
Opportunities include any preferable situation in the present or future that arises 
in the environment of the project, for example, a trend, change, or perceived need that 
supports the demand for project results and allows project management to improve 
their competitive position. 
A threat is any undesirable situation, tendency or change in the environmental 
conditions of a project that is destructive or threatening in nature for its competitiveness 
in the present or in the future. A threat can be a barrier, restriction, or anything else that 
could cause problems, destruction, harm, or damage to the project. 
Table 3.2.1.2-1 _ the Summary table of the SWOT analysis 
 Strengths: 
S1. Accurate dose delivery. 
S2. Development of optimal 
and universal criterial for 
reproducibility based on 
clinical evidence.  
 
Weaknesses: 
W1. Lack of equipment and 
software for dose verification; 
W2. Fewer stuff expertise. 
W3. No known acceptable 





O1. Improved tumor control 
for patients with lung, thorax 
and prostate cancers. 
O2. Increased ability to verify 
calculated dose before patient 
treatment. 
O3. Reduced treatment 
planning time 
Strategy which is based on 
strength and opportunities:  
1.Overall improvement in 
radiation treatment quality 
2.There is confidence that the 
patient receives the prescribed 
dose correctly hence reducing 
underdose and overdose 
errors. 
Strategy which is based on 
weaknesses and opportunities: 
1.conducting clinical based 
studies on different tumor site 
will help provide clinical 
evidence studies which will in 
turn reduce treatment planning 
time. 
2. Acquiring of equipment and 
software, training of medical 
physicists to work with treatment 
planning system (TPS) will help 
improve planning and 
verification QA system thereby 
improving tumor control and 
treatment time. 
Threats: 
T1. Linear accelerator unable 
to deliver segment dose 
intensity as planned in 
treatment planning system. 
T2. Lack of interest among 
clinicians due to lack of 
evidence base in clinical 
research. 
 
Strategy which is based on 
strength and threats:  
1.It is necessary to always 
verify the ability of equipment 
reproducibility so that the 
planned dose is delivered 
accurately during patient 
treatment. 
2.Publication of benefits and 
obtained results from studies 
and application of the 
methodology as standards in 
oncology center will create 
awareness and interest among 
users 
Strategy which is based on 
weaknesses and threats: 
1. Regular training of medical 
stuff will enable them to conduct 
Equipment QA verification  
2. Encouraging clinical case 
studies within the center will help 
acquire interest and improve 
patient specific QA verification.  
 
The results of the SWOT analysis are taken into account when developing the 
structure of work carried out as part of a research project. 
4.3 Project Initiation 
The initiation process group consists of processes that are performed to define 
a new project or a new phase of an existing one. In the initiation processes, the initial 
purpose and content are determined and the initial financial resources are fixed. The 
internal and external stakeholders of the project who will interact and influence the 






Table 3.2.1.2-1 _Stakeholders of the project 
Project stakeholders Stakeholder expectations 
Russian oncological clinic and cancer 
patients 
Provides necessary radiotherapy equipment and 
resources to ensure completion of the project 
Medical physicists 
Create radiotherapy plans and dosimetric plans for 
QA plans 
Provides guidelines to decrease treatment plans 
errors 
Oncologists  
perform regular examination of patients and approve 
radiotherapy plans 
This table shows the stake holders that will benefit from the results of the 
research, we have medical physicists who will have less time to plan for lung, thorax 
and prostate cancer. Quality assurance QA procedure will be less consuming. 
Table 3.2.1.2-2 _Purpose and results of the project 
Purpose of project: 
To determine the optimal minimum segment width of Intensity 
modulated radiotherapy plan in treatment of thorax, lung and 
prostate cancers  
Expected results of the 
project: 
-Consistent dose distribution between planned dose and 
measured dose. 
-Improved target dose coverage and dose reduction to organs at 
risk. 
-Accurate dose delivery and decreased treatment time 
Criteria for acceptance of the 
project result: 
Dose to organs at risk to fall within defined constraints 
Adequate coverage of target volume at the level V95> 95% 
prescribed dose. 
Gamma index of 3%/2mm at 20% threshold with a pass rate 
≥95% 
Requirements for the project 
result: 
The project to be completed by 1 june,2021 and meet the 
acceptance criteria 
Results should be presented at least two conferences and have a 
publication in the medical physics scientific journal. 
Industrial applicability   
Significance for research 
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In this table we see the purpose of the project being highlighted, criteria for 
acceptance of the project results, that is the dose delivered to critical structure should 
fall within the defined constraints, the target volume (PTV) should be covered 
adequately following prescribed dose. To understand the outcome of the results a 
gamma index criterion of 3%/2mm at 20% threshold will be used and with a pass rate 
≥95% to know that the plan has passed. 
 
4.3.1 The organizational structure of the project 
It is necessary to solve some questions: who will be part of the working group 
of this project, determine the role of each participant in this project, and prescribe the 
functions of the participants and their number of labor hours in the project. 
Table 3.2.1.2-1 _The working group of the project 





Head of project  -Formulation of research 
topic and direction of 
research  
-Review and Verification 
of the project 
Control of deadlines and 
research  
45 
2 Master’s student  Executor  -Selection of main 
evaluation and scientific 
literature  
- Analyzing collected 
results 




The table indicates the main working group of people that is the scientific 
supervisor who is the head of the project and the master’s student who is responsible 
for executing the project, alongside is shown the number of hours for the entire project 
for each member the scientific supervisor is accounted for 45 hours while the student 




4.3.2 Project limitations 
Project limitations are all factors that can be as a restriction on the degree of 
freedom of the project team members. 
Table 3.2.1.2-1 _Project limitations 
Factors Limitations / Assumptions 
3.1. Project's budget 306661.63 Rubles  
3.1.1. Source of financing Internal TPU 
3.2. Project timeline: 01.02.2021-01.06.2021 
3.2.1. Date of approval of plan of project 01.02.2021 
3.2.2. Completion date 01.06.2021 
 
This is the summary of the project budget it is scheduled for 01.02.2021 through 
to 01.06.2021. the total amount required is 306661.63 Rubles and the source of financing is 
from the internal TPU. Various aspects were considered in the calculations to finally arrive at 
the stated budget price. 
4.3.3 Project Schedule 
As part of planning a science project, one needs to build a project timeline and a Gantt 
Chart. 
Table 3.2.1.2-1 _project timeline 











approval of the 
Terms of 
Reference 




study of scientific 
literature 
25 18.02.2021 20.03.2021 Master’s student  
Work scheduling 5 22.03.2021 26.03.2021 
Scientific 
supervisor, 
master’s student  
Selection of cases 
and creation of 
RT plans 











Analysis of the 
obtained 
experimental data 





results for report 
preparation  




6 30.04.2021 8.05.2021 Master’s student 
Defense 
preparation 
20 10.05.202 1.06.2021 Master’s student  
 
Here it is shown the time line of the project, and the working group in charge, 
their responsibilities and duration, it is observed that the longer period is required for 
defense preparation and analysis of results. 
A Gantt chart, or Harmon gram, is a type of bar chart that illustrates a project 
schedule. This chart lists the tasks to be performed on the vertical axis, and time 
intervals on the horizontal axis. The width of the horizontal bars in the graph shows 
the duration of each activity.  
Table 3.2.1.2-2 _Calendar schedule of master’s thesis performing 
№ Activities  Participants 
Тc, 
days 
Duration of the project 
February March April May June 
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                          − Scientific supervisor,         − Master’s Student 
4.4 Scientific and technical research budget 
The amount of costs associated with the implementation of this work is the 
basis for the formation of the project budget. This budget will be presented as the lower 
limit of project costs when forming a contract with the customer. 
To form the final cost value, all calculated costs for individual items related to 
the manager and the Technician are summed. 
In the process of budgeting, the following grouping of costs by items is used: 
- Material costs of scientific and technical research; 
- costs of special equipment for scientific work (Depreciation of equipment 
used for design); 
- basic salary; 
- additional salary; 
- labor tax; 
- overhead. 
4.4.1 Calculation of material costs 





m Т i consi
i
C ( k ) P N
=
= +   ,  
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where  m – the number of types of material resources consumed in the 
performance of scientific research; 
Nconsi – the amount of material resources of the i-th species planned to be used 
when performing scientific research (units, kg, m, m2, etc.); 
Pi – the acquisition price of a unit of the i-th type of material resources 
consumed (rub./units, rub./kg, rub./m, rub./m2, etc.); 
kТ – coefficient taking into account transportation costs. 
Prices for material resources can be set according to data posted on relevant 
websites on the Internet by manufacturers (or supplier organizations). 






































Office supplies - 1 800 800 
Internet  month 4 350 1400 
Total 1200 
  
The total cost of materials was calculated and found to be 1200 rubles; 
therefore, this amount is required to successfully obtained the materials for the project. 
4.4.2 Calculation of the depreciation 






А - annual amount of depreciation; 




 - rate of depreciation; 

















the duration of 
the project (rub). 
1. Irradiation unit 1 3000000 60 684.9 
2. 
ArcCHECK-
diode detector  
1 120000 10 164.4 
3. Computer  1 30000 5 1623.6 
Total 2472.9 
  
Following the above formular it was necessary to calculate the depreciation, for 
this project the depreciation amounts to 2472.9 rubles, taking into account the life 
expectancy and the quantity unit. 
4.4.3 Basic salary 
This point includes the basic salary of participants directly involved in the 
implementation of work on this research. The value of salary costs is determined based 
on the labor intensity of the work performed and the current salary system 
The basic salary (Sb) is calculated according to the following formula: 
 , (3.3) 
where   Sb – basic salary per participant; 
Тw – the duration of the work performed by the scientific and technical worker, 
working days; 
Sa - the average daily salary of a participant, rub. 





where  – monthly salary of a participant, rub.; 
М – the number of months of work without leave during the year: 
at holiday in 48 days, M = 11.2 months, 6 day per week; 
– valid annual fund of working time of scientific and technical personnel (251 days). 













                         
Table 3.2.1.2-1 _The valid annual fund of working time 
Working time indicators  
Calendar number of days 365 






Loss of working time 
- vacation 




The valid annual fund of working time 251 
Monthly salary is calculated by formula: 
 
month base premium bonus regS S ( k k ) k=  +  ,   ( 
where  Sbase – base salary, rubles; 
kpremium – premium rate;  
kbonus – bonus rate; 
kreg – regional rate. 

















– – 1,3 
45656 1891,7 45 85127,5 
Master’s 
Student  
17310 22503 932,4 74 68997,6 
Total 154125,1 
 
The monthly basic salary was calculated using the formular stated under 
monthly basic salary. The salary of the scientific supervisor is at 35120 rubles 
according to TPU salary of associate professors, it was the calculated the base salary 
to be 85127,5 rubles. For a person with master’s degree, it is estimated that they are 
paid 17310 rubles and the base salary calculated in this project leads to 68997,6. 
Therefor the total base salary for the working group is 154125,1rubles. 
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4.4.4 Additional salary 
This stage includes the number of payments stipulated by the legislation on 
labor, for example, payment of regular and additional holidays; payment of time 
associated with state and public duties; payment for work experience, etc. 
Additional salaries are calculated on the basis of 10-15% of the base salary of 
workers: 
 
add extra baseW k W=  ,    
where  Wadd – additional salary, rubles; 
kextra – additional salary coefficient (10%);  
Wbase – base salary, rubles. 
Table 14.  _additional salary 
Table 3.2.1.2-1 _additional salary 
Participants  Additional salary  
Scientific supervisor 8512,75 
Master’s student 6899,76 
Total  15412,51 
 
Then it is necessary to calculate additional salary as explained above, the 
additional salary was calculated and is shown to be 15412,51 rubles in total for all 
working group. 
4.4.5 Labor tax 
Tax to extra-budgetary funds is compulsory according to the norms established 
by the legislation of the Russian Federation to the state social insurance (SIF), pension 
fund (PF) and medical insurance (FCMIF) from the costs of workers. 
Payment to extra-budgetary funds is determined of the formula:  
 
social b base addP k (W W )=  +  (х) 
where  kb – coefficient of deductions for labor tax. 
In accordance with the Federal law of July 24, 2009 No. 212-FL, the amount 
of insurance contributions is set at 30%. Institutions conducting educational and 
scientific activities have rate - 27.1%. 
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Table 3.2.1.2-1 _Labor tax 
 Scientific supervisor Master’s Student  
Coefficient of deductions 0.271 
Salary, rubles 93640,25 75897,36 
Labor tax, rubles 25376,5 20568.2 
Total 45944.71 
 
Tax to extra-budgetary funds is compulsory according to the norms established 
by the legislation of the Russian Federation. In this study it was calculated at 27%, the 
records show a total amount of 45944.71 rubles. 
4.4.6 Overhead costs 
Overhead costs include other management and maintenance costs that can be 
allocated directly to the project. In addition, this includes expenses for the maintenance, 
operation and repair of equipment, production tools and equipment, buildings, 
structures, etc. Overhead costs account from 30% to 90% of the amount of base and 
additional salary of employees. Overhead is calculated according to the formula: 
 ov ov base addС k (W W )=  +  ( 
where kov =50% – overhead rate. 
Table 3.2.1.2-1 _Overhead cost 
 Scientific supervisor Master’s student 
Overhead rate 0.5 
Salary, rubles 93640,25 75897,36 
Overhead, rubles 46820,13 37948,7 
Total 84768,81 
 
The overhead cost calculated at 50% for both the scientific supervisor and the 
student amounts to a total of 84768,81rubles taking into account the base salary then 
determining the overhead cost. 
4.4.7 Other direct costs  
Energy costs are calculated by the formula: 
 el eqС P Р F=   ,  
where 
elP  − power rates (5.8 rubles per 1 kWh); 
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Р  − power of equipment, kW; 
eqF  − equipment usage time, hours. 
Assuming that the PC work duration for this research is about 296 hours, where 
it operates 4 hours per day then in 74 days it operates for 222 kW/h(0.75kW). the linear 
accelerator measurement duration is 5 hours if measurement is taken in 1 hour, then in 
5 days the linac operates at 250Kw/h (power is 50Kw). Energy costs which include 
equipment and computer work are calculated by the formula:  
𝐶 = 𝑃𝑒𝑙 × 𝑃 × 𝐹𝑒𝑞 = 5.8 × (50kW × 5hours + 0.75kW × 296hours) = 2737.6  
          


















































1.Energy cost 50 250 5.8 472 
2. Energy cost 0.75 296 5.8 222 
Total 2737.6 
  
The study also took into account other direct cost such as the electricity usage 
by the main equipment used that is the linear accelerator and the computer. The amount 
power was calculated the total cost is 2737.6 rubles. 
4.4.8 Formation of budget costs 
The calculated cost of research is the basis for budgeting project costs.  
Table 3.2.1.2-1 _Items expenses grouping 
Name Cost, rubles 
1. Material costs 1200 
2. Depreciation 2472.9 
3. Basic salary 154125.1 
4. Additional salary 15412.51 
5. Labor tax 45944.71 
6. Overhead 84768.81 
7. Other direct cost 2737.6 




Table 17 indicates the total cost of research that is taking into account the 
material costs, depreciation cost, basic salary, additional salary, labor tax, overhead 
and other direct cost hence the total cost obtained from all calculation is stated at 
306661.63 rubles. 
4.5 Evaluation of the comparative effectiveness of the project 
Determination of efficiency is based on the calculation of the integral indicator 
of the effectiveness of scientific research. Its finding is associated with the definition 
of two weighted average values: financial efficiency and resource efficiency. 
The integral indicator of the financial efficiency of a scientific study is obtained 
in the course of estimating the budget for the costs of three (or more) variants of the 
execution of a scientific study. For this, the largest integral indicator of the 
implementation of the technical problem is taken as the calculation base (as the 
denominator), with which the financial values for all the options are correlated. 
 






ф = , (x) 
where  
p
фI  – integral financial measure of development; 
Фрi – the cost of the i-th version;  
Фmax – the maximum cost of execution of a research project (including 
analogues).The obtained value of the integral financial measure of development 
reflects the corresponding numerical increase in the budget of development costs in 
times (the value is greater than one), or the corresponding numerical reduction in the 
cost of development in times (the value is less than one, but greater than zero). 
Since the development has one performance, then 
p
фI  = 1. 
The integral indicator of the resource efficiency of the variants of the research 






















where   т
I
 – integral indicator of resource efficiency for the i-th version of the 
development;  




ib  – score rating of the i-th version of the development, is established by an expert 
on the selected rating scale;  
n – number of comparison parameters.  
The calculation of the integral indicator of resource efficiency is presented in 
the form of table below, where Pp is project point and Aa is analogy point, the method 
in comparison with project method is 3D-Conformal radiotherapy, taking into account 
weight coefficients are classified as Cp and Ca for project and analogy respectively. 
Table 3.2.1.2-1 _Evaluation of the performance of the project 











Aa Pp Ca Cp 
1 2 3 4 6 7 
Technical criteria for evaluating resource efficiency 
1. Delivery time 0,1 4 5 0,4 0,5 
2. Planning efficiency 0,25 4 4 1 1 
3. Dose conformity 0,05 3 5 0,15 0,25 
4. Energy efficiency 0,2 4 5 0,8 1 
5. Reliability of results 0,1 5 5 0,5 0,5 
6. Hardware availability 0,1 4 4 0,4 0,4 
Economic criteria for performance evaluation 





2. Power application 0,05 4 5 0,2 0,25 
3. Price 0.05 4 4 0,2 0,2 
Total 1 37 42 4,15 4,6 
  The points were evaluated in terms of delivery time, plan efficiency dose 
conformity, power application and many other as can be seen from the table.  
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The integral indicator of the development efficiency (
p
финрI ) is determined on 
the basis of the integral indicator of resource efficiency and the integral financial 


















 and etc. 
(=) 
Comparison of the integral indicator of the current project efficiency and 













Thus, the effectiveness of the development is presented in table 18. 
Table 3.2.1.2-2 _Efficiency of development 
№ Indicator Project Analog 
1 Integral financial indicator 1 1 
2 Integral resource efficiency indicator 4,15 4,6 
3 Integral efficiency indicator 4,15 4,6 




Comparison of the values of integral performance indicators allows us to 
understand and choose a more effective solution to the technical problem from the 











During the calculations, the most important indicators were determined, which 
include: labor costs, social security contributions, overhead costs. The smallest expense 
item is material research costs. An article that makes up the high cost of a scientific 
project is the salary of people directly involved in creating a scientific project. The 
number of work performers is two: master’s student and a supervisor from the TPU 
university. From the implementation of the economic part, calculations were made of 
the planned cost of the scientific project and the time required to carry out this work. 
The planned cost of work is 306661.63 rubles, the main component of which is the 
wages of employees. 
 The financial management, resource efficiency and resource saving analysis it 
can see that a large amount is distributed to paying salaries taking a share of 154125.1 
ruble in basic salary plus additional salaries of 15412.51rubles as well as overhead cost 
taking 84768.81rubles.  In every scientific undertaking financial management, resource 

















Chapter 5 Social responsibility 
5.1 Introduction 
Radiation therapy is a mode of cancer treatment which makes use of radiations, 
it can be delivered externally known as external beam radiotherapy or internally known 
as brachytherapy treatment. Because of this, medical stuffs and patients are at risk of 
exposure to ionizing radiation, not only this but work is done indoors there are harmful 
factors that can arise during work. It is necessary to limit exposure, analyze harmful 
factors that arises and ensuring occupation and public safety by following legal 
recommendations.  This project investigates the influence of minimum segment width 
of intensity modulated radiotherapy (IMRT)plan based on quality assurance (QA) for 
three cancer sites that is lung, thorax and prostate cancer, it important to determine 
optimum and universal minimum segment width (MSW) for IMRT and VMAT plans 
based on 3D dosimetric phantom for thorax cancer, prostate cancer and lung cancer 
treatment. The study was conducted at Tomsk oncology clinic, Russia. The results of 
the project will benefit medical oncologist, medical physicists, and patients with 
prostate, thorax and lung cancer treated with IMRT and VMAT, giving confidence that 
the dose is delivered to the patient as was planned. 
5.2 Legal and organizational items in providing safety 
Nowadays one of the main ways to radical improvement of all prophylactic 
work referred to reduce Total Incidents Rate and occupational morbidity is the 
widespread implementation of an integrated Occupational Safety and Health 
management system. That means combining isolated activities into a single system of 
targeted actions at all levels and stages of the production process. Occupational safety 
is a system of legislative, socio-economic, organizational, technological, hygienic and 
therapeutic and prophylactic measures and tools that ensure the safety, preservation of 
health and human performance in the work process [51]. 
According to the Labor Code of the Russian Federation, every employee has 
the right: 
- to have a workplace that meets Occupational safety requirements; 
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- to have a compulsory social insurance against accidents at manufacturing and 
occupational diseases; 
- to receive reliable information from the employer, relevant government 
bodies and public organizations on conditions and Occupational safety at the 
workplace, about the existing risk of damage to health, as well as measures to protect 
against harmful and (or) hazardous factors; 
- to refuse carrying out work in case of danger to his life and health due to 
violation of Occupational safety requirements; 
- be provided with personal and collective protective equipment in compliance 
with Occupational safety requirements at the expense of the employer; 
- for training in safe work methods and techniques at the expense of the 
employer; 
- for personal participation or participation through their representatives in 
consideration of issues related to ensuring safe working conditions in his workplace, 
and in the investigation of the accident with him at work or occupational disease; 
- for extraordinary medical examination in accordance with medical 
recommendations with preservation of his place of work (position) and secondary 
earnings during the passage of the specified medical examination; 
- for warranties and compensation established in accordance with this Code, 
collective agreement, agreement, local regulatory an act, an employment contract, if he 
is engaged in work with harmful and (or) hazardous working conditions. 
The labor code of the Russian Federation states that normal working hours may 
not exceed 40 hours per week, the employer must keep track of the time worked by 
each employee. 
Rules for labor protection and safety measures are introduced in order to 
prevent accidents, ensure safe working conditions for workers and are mandatory for 
workers, managers, engineers and technicians. 
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5.3 Basic ergonomic requirements for the correct location and 
arrangement of researcher’s workplace 
The workplace when working with a PC should be at least 6 square meters. The 
legroom should correspond to the following parameters: the legroom height is at least 
600 mm, the seat distance to the lower edge of the working surface is at least 150 mm, 
and the seat height is 420 mm. It is worth noting that the height of the table should 
depend on the growth of the operator. 
The following requirements are also provided for the organization of the 
workplace of the PC user: The design of the working chair should ensure the 
maintenance of a rational working posture while working on the PC and allow the 
posture to be changed in order to reduce the static tension of the neck and shoulder 
muscles and back to prevent the development of fatigue. 
The type of working chair should be selected taking into account the growth of 
the user, the nature and duration of work with the PC. The working chair should be 
lifting and swivel, adjustable in height and angle of inclination of the seat and back, as 
well as the distance of the back from the front edge of the seat, while the adjustment of 
each parameter should be independent, easy to carry out and have a secure fit. 
5.4 Occupational safety 
A dangerous factor or industrial hazard is a factor whose impact under certain 
conditions leads to trauma or other sudden, severe deterioration of health of the worker 
[51]. A harmful factor or industrial health hazard is a factor, the effect of which on a 
worker under certain conditions leads to a disease or a decrease in working capacity. 
5.4.1 Analysis of harmful and dangerous factors that can create object of 
investigation 
The object of investigation intensity modulated radiotherapy (IMRT) and 
volumetric modulated arc therapy (VMAT). The IMRT and VMAT plans are scheme 
for delivering ionizing radiation to the tumor. Therefore, object of investigation can 
create harmful factor of increased levels of ionizing radiation while implementing 




5.4.2 Analysis of harmful and dangerous factors that can arise at 
workplace during investigation 
Working conditions in places of work are characterized by presence of 
hazardous and harmful factors, that are categorized in groups of physical, chemical, 
biological, psychophysiological. The main elements of the production process that 
form dangerous and harmful factors are presented in Table 1. 















+ + + 
Sanitary rules 







computers and work 
organization." 
Sanitary rules 
2.2.1 / 2.1.1.1278–03. 
Hygienic requirements 
for natural, artificial 
and combined lighting 
of residential and 
public buildings. 
Sanitary rules 
2.2.4 / 2.1.8.562–96. 
Noise at workplaces, 
in premises of 
2. Excessive 
noise 





+ + + 
4.Insufficient 
illumination of the 
working area 













voltage value in the 
circuit, the closure 
which may occur 
through the human 
body 
+ + + 




levels of touch 
voltages and currents. 
6. Increased 
levels of ionizing 
radiation 
+ + + 
Sanitary 





The following factors effect on person working on a computer: 
physical:  
temperature and humidity;  
noise;  
static electricity;  
electromagnetic field of low purity; 
illumination; 
presence of radiation; 
 psychophysiological: 
 psychophysiological dangerous and harmful factors are divided into:  
physical overload (static, dynamic)  
mental stress (mental overstrain, monotony of work, emotional overload). 
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Deviation of microclimate indicators 
The air of the working area (microclimate) is determined by the following 
parameters: temperature, relative humidity, air speed. The optimum and permissible 
values of the microclimate characteristics are established in accordance with [52] and 
are given in Table 2. 
Table 3.2.1.2-2_Optimal and permissible parameters of the microclimate 
Period of the year Temperature, C Relative humidity,% 
Speed of air 
movement, m/s 
Cold and changing of seasons 23-25 40-60 0.1 
Warm 23-25 40 0.1 
 
Excessive noise 
Noise and vibration worsen working conditions, have a harmful effect on the 
human body, namely, the organs of hearing and the whole body through the central 
nervous system. It results in weakened attention, deteriorated memory, decreased 
response, and increased number of errors in work. Noise can be generated by operating 
equipment, air conditioning units, daylight illuminating devices, as well as spread from 
the outside. When working on a PC, the noise level in the workplace should not exceed 
50 dB. 
Increased level of electromagnetic radiation 
The screen and system blocks produce electromagnetic radiation. Its main part 
comes from the system unit and the video cable. According to [52], the intensity of the 
electromagnetic field at a distance of 50 cm around the screen along the electrical 
component should be no more than: 
- in the frequency range 5 Hz - 2 kHz - 25 V / m; 
- in the frequency range 2 kHz - 400 kHz - 2.5 V / m. 
The magnetic flux density should be no more than: 
- in the frequency range 5 Hz - 2 kHz - 250 nT; 
- in the frequency range 2 kHz - 400 kHz - 25 nT. 
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Abnormally high voltage value in the circuit 
Depending on the conditions in the room, the risk of electric shock to a person 
increases or decreases. Do not operate the electronic device in conditions of high 
humidity (relative air humidity exceeds 75% for a long time), high temperature (more 
than 35 ° C), the presence of conductive dust, conductive floors and the possibility of 
simultaneous contact with metal components connected to the ground and the metal 
casing of electrical equipment. The operator works with electrical devices: a computer 
(display, system unit, etc.) and peripheral devices. There is a risk of electric shock in 
the following cases: 
- with direct contact with current-carrying parts during computer 
repair; 
- when touched by non-live parts that are under voltage (in case of 
violation of insulation of current-carrying parts of the computer); 
- when touched with the floor, walls that are under voltage; 
- short-circuited in high-voltage units: power supply and display unit. 
Table 3.2.1.2-3_Upper limits for values of contact current and voltage 
 Voltage, V Current, mA 
Alternate, 50 Hz 2 0.3 
Alternate, 400 Hz 3 0.4 
Direct 8 1.0 
 
Insufficient illumination of the working area 
Light sources can be both natural and artificial. The natural source of the light 
in the room is the sun, artificial light are lamps. With long work in low illumination 
conditions and in violation of other parameters of the illumination, visual perception 
decreases, myopia, eye disease develops, and headaches appear. 
According to the standard, the illumination on the table surface in the area of 
the working document should be 300-500 lux. Lighting should not create glare on the 
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surface of the monitor. Illumination of the monitor surface should not be more than 
300 lux. 
The brightness of the lamps of common light in the area with radiation angles 
from 50 to 90° should be no more than 200 cd/m, the protective angle of the lamps 
should be at least 40°. The safety factor for lamps of common light should be assumed 
to be 1.4. The ripple coefficient should not exceed 5%. 
Increased levels of ionizing radiation 
Ionizing radiation is radiation that could ionize molecules and atoms. This 
effect is widely used in energetics and industry. However, there is health hazard. In 
living tissue, this radiation could damage cells that result in two types of effects. 
Deterministic effects (harmful tissue reactions) due to exposure with high doses and 
stochastic effects due to DNA destruction and mutations (for example, induction of 
cancer). 
To provide radiation safety with using sources of ionizing radiation one must 
use next principles: 
keep individual radiation doses from all radiation sources not higher than 
permissible exposure; 
forbid all activity with using radiation sources if profit is low than risk of 
possible hazard; 
keep individual radiation doses from all radiation sources as low as possible. 
There are two groups of people related to work with radiation: personnel, who 
works with ionizing radiation, and population as in table 5-4. 





20 mSv per year in average 
during 5 years, but not higher 
than 50 mSv per year 
1 mSv per year in average 
during 5 years, but not higher 
than 5 mSv per year 
Equivalent dose 
per year in eye’s 
lens 
150 mSv 15 mSv 
skin 500 mSv 50 mSv 




Effective dose for personnel must not exceed 1000 mSv for 50 years of working 
activity, and for population must not exceed 70 mSv for 70 years of life. 
In addition, for women from personnel of age below 45 years there is limit of 
1 mSv per month of equivalent dose on lower abdomen. During gestation and breast-
feeding women must not work with radiation sources. 
For students older than 16, who uses radiation sources in study process or who 
is in rooms with increased level of ionizing radiation, dose limits are quarter part of 
dose limits of personnel. 
5.4.3 Justification of measures to reduce the levels of exposure to 
hazardous and harmful factors on the researcher 
Deviation of microclimate indicators 
The measures for improving the air environment in the production room 
include: the correct organization of ventilation and air conditioning, heating of room. 
Ventilation can be realized naturally and mechanically. In the room, the following 
volumes of outside air must be delivered:  
- at least 30 m 3 per hour per person for the volume of the room up to 
20 m 3 per person;  
- natural ventilation is allowed for the volume of the room more than 
40 m 3 per person and if there is no emission of harmful substances. 
The heating system must provide sufficient, constant and uniform heating of 
the air. Water heating should be used in rooms with increased requirements for clean 
air.  
The parameters of the microclimate in the laboratory regulated by the central 
heating system, have the following values: humidity 40%, air speed 0.1 m / s, summer 
temperature 20-25 ° C, in winter 13-15 ° C. Natural ventilation is provided in the 
laboratory. Air enters and leaves through the cracks, windows, doors. The main 
disadvantage of such ventilation is that the fresh air enters the room without 





In research audiences, there are various kinds of noises that are generated by 
both internal and external noise sources. The internal sources of noise are working 
equipment, personal computer, printer, ventilation system, as well as computer 
equipment of other engineers in the audience. If the maximum permissible conditions 
are exceeded, it is sufficient to use sound-absorbing materials in the room (sound-
absorbing wall and ceiling cladding, window curtains). To reduce the noise penetrating 
outside the premises, install seals around the perimeter of the doors and windows. 
Increased level of electromagnetic radiation 
There are the following ways to protect against EMF: 
- increase the distance from the source (the screen should be at least 50 cm from 
the user); 
- the use of pre-screen filters, special screens and other personal protective 
equipment. 
When working with a computer, the ionizing radiation source is a display. 
Under the influence of ionizing radiation in the body, there may be a violation of 
normal blood coagulability, an increase in the fragility of blood vessels, a decrease in 
immunity, etc. The dose of irradiation at a distance of 20 cm to the display is 50 µrem 
/ hr. According to the norms [52], the design of the computer should provide the power 
of the exposure dose of x-rays at any point at a distance of 0.05 m from the screen no 
more than 100 µR / h. 
Fatigue of the organs of vision can be associated with both insufficient 
illumination and excessive illumination, as well as with the wrong direction of light. 
Increased levels of ionizing radiation 
In case of radiation accident, responsible personnel must take all measures to 
restore control of radiation sources and reduce to minimum radiation doses, number of 
irradiated persons, radioactive pollution of the environment, economic and social 
losses caused with radioactive pollution. 
Radiation control is a main part of radiation safety and radiation protection.  It 
is aimed at not exceeding the established basic dose limits and permissible levels of 
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radiation, obtaining the necessary information to optimize protection and making 
decisions about interference in the case of radiation accidents, contamination of the 
environment and buildings with radionuclides. 
The radiation control is control of: 
• Radiation characteristics of radiation sources, pollution in air, liquid and 
solid wastes. 
• Radiation factors developed with technological processes in working 
places and environment. 
• Radiation factors of contaminated environment. 
• Irradiation dose levels of personnel and population. 
The main controlled parameters are: 
• Annual effective and equivalent doses 
• intake and body content of radionuclides 
• volume or specific activity of radionuclides in air, water, food products, 
building materials and etc. 
• radioactive contamination of skin, clothes, footwear, working places and 
etc. 
• dose and power of external irradiation. 
• particles and photons flux density. 
Radiation protection office establish control levels of all controlled parameters 
in according to not exceed dose limits and keep dose levels as low as possible. In case 
of exceeding control levels radiation protection officers start investigation of exceed 
causes and take actions to eliminate this exceeding. 
During planning and implementation of radiation safety precautions, taking any 
actions about radiation safety and analysis of effectiveness of mentioned action and 
precautions one must value radiation safety with next factors: 
• characteristics of radioactive contamination of the environment; 
• probability of radiation accidents and scale of accidents; 




• number of persons irradiated with doses higher than controlled limits of 
doses; 
• analysis of actions for providing radiation safety, meeting requirements, 
rules, standards of radiation safety; 
• analysis of irradiation doses obtained by groups of population from all 
ionizing radiation sources. 
Abnormally high voltage value in the circuit 
Measures to ensure the electrical safety of electrical installations: 
- disconnection of voltage from live parts, on which or near to which 
work will be carried out, and taking measures to ensure the 
impossibility of applying voltage to the workplace; 
- posting of posters indicating the place of work; 
- electrical grounding of the housings of all installations through a 
neutral wire; 
- coating of metal surfaces of tools with reliable insulation; 
- inaccessibility of current-carrying parts of equipment (the 
conclusion in the case of electroporating elements, the conclusion 
in the body of current-carrying parts) [53]. 
Insufficient illumination of the working area 
Desktops should be placed in such a way that the monitors are oriented 
sideways to the light openings, so that natural light falls mainly on the left. 
Also, as a means of protection to minimize the impact of the factor, local 
lighting should be installed due to insufficient lighting, window openings should be 
equipped with adjustable devices such as blinds, curtains, external visors, etc. 
5.5 Ecological safety 
5.5.1 Analysis of the impact of the linear accelerator on the environment 
Sources of ionizing radiation used in medicine could be divided into two 
groups: radioactive substances and radiation generators. The difference is that radiation 
92 
 
generators like accelerators and x-ray tubes emit ionizing radiation only when they are 
turned on.   
In ordinary work with necessary safety precautions, there are insignificant 
impact of using sources of ionizing radiation on environment. The immediate effect of 
ionizing radiation is ionization of air in room, but after a specified time the ionization 
disappears. 
The danger of using radioactive materials could occur only in accidents with 
stealing and loosing these materials due to high toxicity. 
5.5.2 Analysis of the environmental impact of the research process 
Process of investigation itself in the thesis do not have essential effect on 
environment. One of hazardous waste is fluorescent lamps. Mercury in fluorescent 
lamps is a hazardous substance and its improper disposal greatly poisons the 
environment. 
Outdated devices go to an enterprise that has the right to process wastes. It is 
possible to isolate precious metals with a purity in the range of 99.95–99.99% from 
computer components. A closed production cycle consists of the following stages: 
primary sorting of equipment; the allocation of precious, ferrous and non-ferrous 
metals and other materials; melting; refining and processing of metals. Thus, there is 
an effective disposal of computer devices. 
5.5.3 Justification of environmental protection measures 
Pollution reduction is possible due to the improvement of devices that produces 
electricity, the use of more economical and efficient technologies, the use of new 
methods for generating electricity and the introduction of modern methods and 
methods for cleaning and neutralizing industrial waste. In addition, this problem should 
be solved by efficient and economical use of electricity by consumers themselves. This 
is the use of more economical devices, as well as efficient regimes of these devices. 
This also includes compliance with production discipline in the framework of the 
proper use of electricity [53]. 
Simple conclusion is that it is necessary to strive to reduce energy consumption, 
to develop and implement systems with low energy consumption. In modern 
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computers, modes with reduced power consumption during long-term idle are widely 
used. 
5.6 Safety in emergency 
5.6.1 Analysis of probable emergencies that may occur at the workplace 
during research 
The fire is the most probable emergency in our life. Possible causes of fire: 
- malfunction of current-carrying parts of installations; 
- work with open electrical equipment; 
- short circuits in the power supply; 
- non-compliance with fire safety regulations; 
- presence of combustible components: documents, doors, tables, cable 
insulation, etc. 
Activities on fire prevention are divided into: organizational, technical, 
operational and regime. 
5.6.2 Substantiation of measures for the prevention of emergencies and the 
development of procedures in case of emergencies 
Organizational measures provide for correct operation of equipment, proper 
maintenance of buildings and territories, fire instruction for workers and employees, 
training of production personnel for fire safety rules, issuing instructions, posters, and 
the existence of an evacuation plan. 
The technical measures include compliance with fire regulations, norms for the 
design of buildings, the installation of electrical wires and equipment, heating, 
ventilation, lighting, the correct placement of equipment [54]. 
The regime measures include the establishment of rules for the organization of 
work, and compliance with fire-fighting measures. To prevent fire from short circuits, 
overloads, etc., the following fire safety rules must be observed: 
- elimination of the formation of a flammable environment (sealing 
equipment, control of the air, working and emergency ventilation); 
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- use in the construction and decoration of buildings of non-combustible or 
difficultly combustible materials; 
- the correct operation of the equipment (proper inclusion of equipment in 
the electrical supply network, monitoring of heating equipment); 
- correct maintenance of buildings and territories (exclusion of the source 
of ignition - prevention of spontaneous combustion of substances, restriction of 
fireworks); 
- training of production personnel in fire safety rules; 
- the publication of instructions, posters, the existence of an evacuation 
plan; 
- compliance with fire regulations, norms in the design of buildings, in the 
organization of electrical wires and equipment, heating, ventilation, lighting; 
- the correct placement of equipment; 
- well-time preventive inspection, repair and testing of equipment. 
In the case of an emergency, it is necessary to: 
- inform the management (duty officer); 
- call the Emergency Service or the Ministry of Emergency Situations - tel. 
112; 















In this section about social responsibility the hazardous and harmful factors 
were revealed. All necessary safety measures and precaution to minimize probability 
of accidents and traumas during investigation are given.  
Possible negative effect on environment were given in compact form describing 
main ecological problem of using nuclear energy.  
It could be stated that with respect to all regulations and standards, investigation 
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